Once-weekly insulin approved in UK for type 2 diabetes in adults
The MHRA has authorised Onswik, a basal insulin injected once a week, and NICE has backed it for NHS use, mainly to cut time spent helping people inject.
13 October 2026
Clinical trials, drug development and research news
Tag
The MHRA has authorised Onswik, a basal insulin injected once a week, and NICE has backed it for NHS use, mainly to cut time spent helping people inject.
13 October 2026